BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ — Lyfegen, a global leader in drug rebate management technology, today announced the successful close of its additional CHF 5 million Series A funding round. The round was led by TX Ventures, a leading European fintech investor,…
